Načítá se...
No Difference on Adherence Between Immediate‐Release Versus Extended‐Release Dopamine Agonists in Uninsured Subjects with Parkinson's Disease
BACKGROUND: Pharmacological management of subjects with Parkinson's disease (PD) is complex. Regardless of drug selection, adherence is one of the main concerns. Nonadherence is associated with poor symptomatic control and low quality of life. In general, adherence to once‐a‐day formulations is...
Uloženo v:
| Vydáno v: | Mov Disord Clin Pract |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
John Wiley and Sons Inc.
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6178727/ https://ncbi.nlm.nih.gov/pubmed/30363523 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/mdc3.12226 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|